These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 39086352)
1. FOXM1 mediates methotrexate resistance in osteosarcoma cells by promoting autophagy. Wang L; Zhai D; Tang L; Zhang H; Wang X; Ma N; Zhang X; Cheng M; Shen R Acta Biochim Biophys Sin (Shanghai); 2024 Jul; 56(9):1289-1299. PubMed ID: 39086352 [TBL] [Abstract][Full Text] [Related]
2. Cadmium chloride enhances cisplatin sensitivity in osteosarcoma cells by reducing FOXM1 expression. Hu K; Xie W; Ni S; Yan S; Tian G; Qi W; Duan Y Oncol Rep; 2020 Aug; 44(2):650-660. PubMed ID: 32627005 [TBL] [Abstract][Full Text] [Related]
3. Loss of Malignancy of Super-Methotrexate-resistant Osteosarcoma Cells Is Associated With an Increase of Methylated Histone Marks H3K9me3 and H3K27me3. Aoki Y; Kubota Y; Masaki N; Obara K; Tome Y; Bouvet M; Nishida K; Hoffman RM Anticancer Res; 2024 Oct; 44(10):4213-4218. PubMed ID: 39348992 [TBL] [Abstract][Full Text] [Related]
4. miR-192 enhances sensitivity of methotrexate drug to MG-63 osteosarcoma cancer cells. Bazavar M; Fazli J; Valizadeh A; Ma B; Mohammadi E; Asemi Z; Alemi F; Maleki M; Xing S; Yousefi B Pathol Res Pract; 2020 Nov; 216(11):153176. PubMed ID: 32861171 [TBL] [Abstract][Full Text] [Related]
5. LncRNA Sox2OT-V7 promotes doxorubicin-induced autophagy and chemoresistance in osteosarcoma via tumor-suppressive miR-142/miR-22. Zhu K; Yuan Y; Wen J; Chen D; Zhu W; Ouyang Z; Wang W Aging (Albany NY); 2020 Apr; 12(8):6644-6666. PubMed ID: 32302291 [TBL] [Abstract][Full Text] [Related]
6. SPAG5 promotes osteosarcoma metastasis via activation of FOXM1/MMP2 axis. Li Z; Li H; Chen J; Luo H; Zeng J; Yao Y; Duan M Int J Biochem Cell Biol; 2020 Sep; 126():105797. PubMed ID: 32668328 [TBL] [Abstract][Full Text] [Related]
7. miR-29 Family Inhibits Resistance to Methotrexate and Promotes Cell Apoptosis by Targeting COL3A1 and MCL1 in Osteosarcoma. Xu W; Li Z; Zhu X; Xu R; Xu Y Med Sci Monit; 2018 Dec; 24():8812-8821. PubMed ID: 30518744 [TBL] [Abstract][Full Text] [Related]
8. Estrogen-related receptor alpha confers methotrexate resistance via attenuation of reactive oxygen species production and P53 mediated apoptosis in osteosarcoma cells. Chen P; Wang H; Duan Z; Zou JX; Chen H; He W; Wang J Biomed Res Int; 2014; 2014():616025. PubMed ID: 24967384 [TBL] [Abstract][Full Text] [Related]
9. Autophagy in osteosarcoma. O'Farrill JS; Gordon N Adv Exp Med Biol; 2014; 804():147-60. PubMed ID: 24924173 [TBL] [Abstract][Full Text] [Related]
10. Reduced Malignancy of Super Methotrexate-resistant Osteosarcoma Cells With Dihydrofolate Reductase Amplification Despite Paradoxical Gain of Oncogenic PI3K/AKT/mTOR and c-MYC expression. Aoki Y; Kubota Y; Masaki N; Obara K; Tome Y; Bouvet M; Nishida K; Hoffman RM Anticancer Res; 2024 Jul; 44(7):2787-2792. PubMed ID: 38925854 [TBL] [Abstract][Full Text] [Related]
11. LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR-361-5p and FoxM1. Shen B; Zhou N; Hu T; Zhao W; Wu D; Wang S J Cell Physiol; 2019 Aug; 234(8):13464-13480. PubMed ID: 30624782 [TBL] [Abstract][Full Text] [Related]
12. HSP90AA1-mediated autophagy promotes drug resistance in osteosarcoma. Xiao X; Wang W; Li Y; Yang D; Li X; Shen C; Liu Y; Ke X; Guo S; Guo Z J Exp Clin Cancer Res; 2018 Aug; 37(1):201. PubMed ID: 30153855 [TBL] [Abstract][Full Text] [Related]
13. MiR-216b inhibits osteosarcoma cell proliferation, migration, and invasion by targeting Forkhead Box M1. Wang W; Guo Z; Yu H; Fan L J Cell Biochem; 2019 Apr; 120(4):5435-5443. PubMed ID: 30302807 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-149 Increases the Sensitivity of Colorectal Cancer Cells to 5-Fluorouracil by Targeting Forkhead Box Transcription Factor FOXM1. Liu X; Xie T; Mao X; Xue L; Chu X; Chen L Cell Physiol Biochem; 2016; 39(2):617-29. PubMed ID: 27415661 [TBL] [Abstract][Full Text] [Related]
15. Cirsiliol induces autophagy and mitochondrial apoptosis through the AKT/FOXO1 axis and influences methotrexate resistance in osteosarcoma. Luo M; Su Z; Gao H; Tan J; Liao R; Yang J; Lin L J Transl Med; 2023 Dec; 21(1):907. PubMed ID: 38087310 [TBL] [Abstract][Full Text] [Related]
16. S-phase kinase-associated protein 2 is involved in epithelial-mesenchymal transition in methotrexate-resistant osteosarcoma cells. Ding L; Wang C; Cui Y; Han X; Zhou Y; Bai J; Li R Int J Oncol; 2018 Jun; 52(6):1841-1852. PubMed ID: 29620168 [TBL] [Abstract][Full Text] [Related]
17. Clinical impact of the methotrexate resistance-associated genes C-MYC and dihydrofolate reductase (DHFR) in high-grade osteosarcoma. Scionti I; Michelacci F; Pasello M; Hattinger CM; Alberghini M; Manara MC; Bacci G; Ferrari S; Scotlandi K; Picci P; Serra M Ann Oncol; 2008 Aug; 19(8):1500-1508. PubMed ID: 18385200 [TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA LUCAT1 modulates methotrexate resistance in osteosarcoma via miR-200c/ABCB1 axis. Han Z; Shi L Biochem Biophys Res Commun; 2018 Jan; 495(1):947-953. PubMed ID: 29170124 [TBL] [Abstract][Full Text] [Related]
19. Circ-FOXM1 promotes the proliferation, migration and EMT process of osteosarcoma cells through FOXM1-mediated Wnt pathway activation. Zhang H; Zhou Q; Shen W J Orthop Surg Res; 2022 Jul; 17(1):344. PubMed ID: 35799265 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-370 directly targets FOXM1 to inhibit cell growth and metastasis in osteosarcoma cells. Duan N; Hu X; Yang X; Cheng H; Zhang W Int J Clin Exp Pathol; 2015; 8(9):10250-60. PubMed ID: 26617733 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]